PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
The Parker Institute for Cancer Immunotherapy brings together the best scientists, clinicians and industry partners to build a smarter and more coordinated cancer immunotherapy research effort to save lives.
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
Founded:
2016-04-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Apache Wordpress Plugins
Similar Organizations
Clincierge
Clincierge enables patients to connect more effectively with clinical trials of new medicines.
HealthVerity
HealthVerity powers the discovery, licensing, and linkage of traditional and emerging healthcare data.
VitalTrax
VitalTrax connects patients with clinical trials with its cloud-based clinical trial network.
Current Advisors List
Board_member
Board_member
Current Employees Featured
Lewis Lanier Director @ Parker Institute for Cancer Immunotherapy
Director
2015-07-01
Susan Schultz Vice President of Business Operations @ Parker Institute for Cancer Immunotherapy
Vice President of Business Operations
2016-07-01
Sean Parker Chairman @ Parker Institute for Cancer Immunotherapy
Chairman
Crystal Mackall Director, Parker Institute for Cancer Immunotherapy at Stanford @ Parker Institute for Cancer Immunotherapy
Director, Parker Institute for Cancer Immunotherapy at Stanford
2016-06-01
Charles Michael Yim Donor @ Parker Institute for Cancer Immunotherapy
Donor
2020-03-01
Jeffrey Bluestone President & CEO @ Parker Institute for Cancer Immunotherapy
President & CEO
2015-04-01
Melinda Griffith Vice President Of Strategic Alliance Management & Chief Legal Counsel @ Parker Institute for Cancer Immunotherapy
Vice President Of Strategic Alliance Management & Chief Legal Counsel
2016-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-06 | ArsenalBio | Parker Institute for Cancer Immunotherapy investment in Series B - ArsenalBio | 220 M USD |
| 2022-06-09 | Senti Biosciences | Parker Institute for Cancer Immunotherapy investment in Post-IPO Equity - Senti Biosciences | 50.6 M USD |
| 2022-03-22 | Affini-T Therapeutics | Parker Institute for Cancer Immunotherapy investment in Venture Round - Affini-T Therapeutics | 175 M USD |
| 2019-10-17 | ArsenalBio | Parker Institute for Cancer Immunotherapy investment in Series A - ArsenalBio | 85 M USD |
| 2018-04-19 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Series A - Tmunity Therapeutics | 35 M USD |
| 2018-01-23 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Series A - Tmunity Therapeutics | 100 M USD |
| 2017-09-14 | ImaginAb | Parker Institute for Cancer Immunotherapy investment in Venture Round - ImaginAb | 8 M USD |
| 2015-12-09 | Tmunity Therapeutics | Parker Institute for Cancer Immunotherapy investment in Seed Round - Tmunity Therapeutics | 10 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-23 | Parker Institute Adds John Connolly as New Chief Scientific Officer |
More informations about "Parker Institute for Cancer Immunotherapy"
The Parker Institute for Cancer Immunotherapy
Over 40 laboratories and more than 300 researchers and immunologists from the country’s leading cancer centers are part of the network. Each Parker Institute research center receives comprehensive funding, and access to dedicated …See details»
Karen Knudsen, MBA PhD, Appointed Chief Executive …
5 days ago About the Parker Institute for Cancer Immunotherapy. The Parker Institute for Cancer Immunotherapy (PICI) is a 501c3 nonprofit organization driving the next generation of cancer treatment by accelerating the …See details»
Karen Knudsen, MBA PhD, Appointed Chief Executive …
4 days ago The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new chief executive officer. A visionary leader in oncology, healthcare ...See details»
Parker Institute for Cancer Immunotherapy Names …
5 days ago The Parker Institute for Cancer Immunotherapy announced the appointment of Karen E. Knudsen, MBA, PhD, as the new Chief Executive Officer (CEO) of the institute.A visionary leader in oncology, health-care delivery, …See details»
Karen E. Knudsen, MBA, PhD - Parker Institute for Cancer …
Karen E. Knudsen, MBA, PhD is the Chief Executive Officer of the Parker Institute for Cancer Immunotherapy (PICI). A globally recognized cancer scientist and executive leader, she brings …See details»
Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy (PICI) is an unprecedented collaboration among the world’s leading researchers, doctors, and cancer centers, all dedicated to a single mission: accelerate the development of …See details»
Tech leader’s $125m boosts Parker Institute’s …
Jul 19, 2024 The Parker Institute for Cancer Immunotherapy (PICI), a research network launched by Silicon Valley entrepreneur Sean Parker, has announced a new $125 million investment. This is the largest investment for the network …See details»
As Trump Cuts Cancer Research Funding, Billionaire …
4 days ago In this environment, he also sees a bigger role for the Parker Institute for Cancer Immunotherapy (PICI), a philanthropic organization he founded nearly a decade ago with a $250 million grant that ...See details»
Parker Institute for Cancer Immunotherapy | Memorial …
The Parker Institute for Cancer Immunotherapy is an unprecedented collaboration among 300 of the country’s leading immunologists at six academic cancer centers, all dedicated to a single mission: harnessing the power of the immune …See details»
Our Story | Parker Institute for Cancer Immunotherapy | Perelman …
Established by Funds from the Parker Foundation, The Parker Institute for Cancer Immunotherapy at the University of Pennsylvania (PICI@Penn) was established in July 2015 …See details»
Parker Institute for Cancer Immunotherapy (PICI ... - Cornell …
The Parker Institute for Cancer Immunotherapy (PICI) is radically changing how cancer research is done. Founded in 2016 through a $250 million gift from Silicon Valley entrepreneur and …See details»
Parker Institute’s Quest to Make Immunotherapy Work in Solid …
3 days ago “The most effective therapies in solid tumors are also the most toxic—and we need to fix that,” says Dr. John Connolly, Chief Scientific Officer of the Parker Institute for Cancer …See details»
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of …
4 days ago The Parker Institute for Cancer Immunotherapy (PICI) is a 501c3 nonprofit organization driving the next generation of cancer treatment by accelerating the development …See details»
Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb …
Mar 28, 2017 CRI is a nonprofit organization dedicated to advancing laboratory and clinical research through its global network of academic, industry, and nonprofit partners with the goal …See details»
Sean Parker - Parker Institute for Cancer Immunotherapy
In April 2016, the Parker Foundation announced a $250 million grant to form the Parker Institute for Cancer Immunotherapy, building on Mr. Parker’s leadership in funding and promoting …See details»
Mitul Gandhi, MD - Virginia Cancer Specialists
Feb 1, 2025 Since joining Virginia Cancer Specialists, Dr. Gandhi has become co-director of the Virginia Cancer Specialists Research Institute and is the Director of the Hematology Trials …See details»
Parker Institute for Cancer Immunotherapy
The Parker Institute for Cancer Immunotherapy has established an unprecedented collaboration that brings together more than 300 of the country's leading immunologists at top cancer …See details»
Kevin S. Choe, MD, PhD - Radiation Oncology
He has published numerous research articles and book chapters on cancer biology and clinical oncology, some of which have been featured in the New York Times and NPR. His work has …See details»
Geoffrey D. Moorer, MD - Virginia Cancer Specialists
Feb 14, 2025 Dr. Moorer holds memberships in several organizations including the American Society of Clinical Oncology, the American Society of Hematology and the National Medical …See details»
David Z. Chang, M.D., Ph.D., FACP - virginiacancer.com
Cleveland Clinic Foundation | Internal Medicine. Residency. Cleveland Clinic Foundation | Internal Medicine. ... /National Cancer Institute (NCI). ... Journal of Immunotherapy, Clinical Cancer …See details»